bioRxivNeurosciencePreprint
Mismatch repair dissection by in vivo RNAi reveals dose-dependent modulators of somatic instability and proteome remodeling in Huntingtons disease
Jillian BelgradiD, Todd M. GrecoiD, Ellen SappiD, Ashley SummersiD, Daniel O’ReillyiD, Eric LuuiD, Josiah E. HuttoniD, Nozomi Yamada, Hassan H. FakihiD, Raymond C. FurgaliD, Dimas EcheverriaiD, Nicholas McHughiD, Brianna M. BramatoiD, Chantal Ferguson, Samuel R. HildebrandiD, Sarah AlleniD, Nicholas GastoniD, David CooperiD, Allison MaebiusiD, Katherine Y. GrossiD, Th. Vogt, Michael FinleyiD, Brinda C. PrasadiD, Marian DiFigliaiD, Ileana M. CristeaiD, , Anastasia KhvorovaiD
Abstract
Human and mouse genetics have established mismatch repair (MMR) as a central mediator of somatic repeat expansion, a key pathogenic process in Huntingtons disease (HD) and related disorders. How individual MMR components function within the intact mammalian brain and interact with broader cellular networks remains poorly understood. We screened more than 500 chemically stabilized siRNAs targeting 10 MMR genes and used interventional RNAi in the Q111 HD mouse model to systematically dissect MMR function in vivo. MSH3 and PMS1 emerged as the most dose-sensitive regulators of somatic expansion but displayed markedly different effects on proteome stability. Quantitative proteomics generated an in vivo atlas of MMR component abundance and cross-regulation in the mammalian CNS, uncovering extensive connectivity between DNA repair, transcriptional regulation, chromatin remodeling, and mitochondrial biology. Together, these findings establish a systems-level framework linking MMR biology to neuronal function and offer mechanistic insight into selective neuronal vulnerability in HD.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeted quantification assays for DNA repair and handling proteins and interactions in Huntington's disease models
Todd M. Greco, Josiah E. Hutton, … Ileana M. Cristea·bioRxiv·Jul 29, 2026
- Blocking somatic repeat expansion and lowering huntingtin via RNA interference synergize to prevent Huntingtons disease pathogenesis in mice
Jillian Belgrad, Ashley Summers, … Anastasia Khvorova·bioRxiv·Jun 24, 2025
- Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice
Nan Wang, Shasha Zhang, … X. William Yang·bioRxiv·Jul 9, 2024
- Di-valent siRNA Mediated Silencing of MSH3 Blocks Somatic Repeat Expansion in Mouse Models of Huntington's Disease
Daniel O’Reilly, Jillian Belgrad, … Anastasia Khvorova·Molecular TherapyPeer-reviewed·May 11, 2023
- Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington's disease
Ross Ferguson, Robert Goold, … Sarah J. Tabrizi·bioRxiv·Dec 5, 2023
- Somatic CRISPR editing of Msh3 mitigates Huntington's disease pathology in mice
Esaria Oliver, Marina V. Kovalenko, … Vanessa Chantal Wheeler·bioRxiv·Jun 10, 2026